Related Experiment Video
Updated: Jan 20, 2026

Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
Published on: April 30, 2023
Change in corneal endothelial cell density after phacoemulsification in patients with type II diabetes mellitus
Muhammad Khalid1, Muhammad Kashif Hanif2, Qamar Ul Islam3
1Dr. Muhammad Khalid, MBBS. Department of Ophthalmology, PNS SHIFA, Karachi, Pakistan.
Objective:
To compare the mean change in Corneal Endothelial cell Density (CED), from baseline (pre-operative value), two months after phacoemulsification cataract surgery between type II diabetic patients and non-diabetic patients.
Methods:
This prospective stratified controlled study was conducted at PNS Shifa Hospital, Karachi. 80 eyes of 72 type II diabetic patients and 80 eyes of 77 non diabetic controls, having Nuclear Opalescence (NO) grades 2 and 3 on slit lamp examination underwent phacoemulsification surgery. CED was measured in cells/mm2, of concerned eye of each subject preoperatively and 2 months post operatively using specular microscope. The difference in mean CED change between the two groups after surgery was analyzed.
Results:
Mean age of study population was 61.41± 6.76 years. Out of study population, 92 (57.5%) were males and 68 (42.5%) were females. There was a statistically significant difference between both groups in terms of mean post-operative CED, mean change in CED and mean frequency change in CED (p <0.05). There was no statistically significant difference between both groups in age, gender, laterality of eyes and mean pre-operative CED, (p >0.05). Difference of pre-operative CED from post-operative CED in each group was statistically significant.
Conclusion:
There is a significant difference between diabetic population and normal population in terms of corneal endothelial loss after uneventful phacoemulsification cataract surgery.
Related Concept Videos
04:26Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
10:03A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
08:36A Porcine Corneal Endothelial Organ Culture Model Using Split Corneal Buttons
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
